Fourth wave

Science Times - Johnson & Johnson Booster Seen with 85-Percent Efficacy; South African Study Reveals Effectiveness of the COVID-19 Vaccine Against Omicron Varian

Johnson & Johnson Booster Efficacy At 85% Found Effective Against COVID-19 Omicron Variant, South African Study Reveals

Medicine & Technology Jan 14, 2022

The head of South Africa's Medical Research Council or SAMRC, Glenda Gray recently claimed that the COVID-19 vaccine booster shot developed by Johnson and Johnson has 85-percent efficacy.

Fourth wave

Johnson & Johnson Booster Efficacy At 85% Found Effective Against COVID-19 Omicron Variant, South African Study Reveals

Most Popular

How Technology Is Changing the Real Estate Industry?

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Why It's So Difficult to Lose Weight: The Biological Explanation Behind Obesity

Nikolay Karpenko Biography, Photo, Career, Accomplishments

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission